Piramal Pharma Limited (NSE:PPLPHARMA)

Piramal Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	326,746	181,305	297,962	170,528	81,683	-
Market Cap Growth	26.70%	-39.15%	74.73%	108.77%	-	-
Enterprise Value	377,399	222,374	341,742	209,922	130,128	-
Last Close Price	245.07	136.54	224.60	128.72	66.76	-

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	-	-	326.96	956.95	-	-
Forward PE	89.77	82.54	70.54	42.33	40.39	-
PS Ratio	3.34	2.04	3.26	2.09	1.15	-
PB Ratio	4.00	2.22	3.67	2.15	1.21	-
P/TBV Ratio	9.12	4.51	7.38	4.71	3.51	-
P/FCF Ratio	-	23.78	130.73	58.30	-	-
P/OCF Ratio	28.32	10.97	33.39	16.98	16.88	-
PEG Ratio	-	0.74	0.44	1.58	1.35	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	3.86	2.51	3.73	2.57	1.84	-
EV/EBITDA Ratio	30.89	26.62	24.92	18.43	22.58	-
EV/EBIT Ratio	99.63	232.39	54.01	45.62	-	-
EV/FCF Ratio	-	29.16	149.94	71.77	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.72	0.70	0.60	0.60	0.83	0.62
Debt / EBITDA Ratio	5.06	6.47	3.44	4.00	9.21	3.63
Debt / FCF Ratio	-	7.49	21.31	16.10	-	-
Net Debt / Equity Ratio	0.62	0.53	0.55	0.53	0.74	0.57
Net Debt / EBITDA Ratio	4.56	5.22	3.24	3.68	8.70	3.47
Net Debt / FCF Ratio	-31.18	5.71	19.52	14.34	-10.43	-31.27
Asset Turnover	0.56	0.53	0.59	0.55	0.52	0.57
Inventory Turnover	1.31	1.33	1.58	1.69	1.94	1.87
Quick Ratio	0.60	0.76	0.75	0.61	0.64	0.69
Current Ratio	1.41	1.51	1.54	1.25	1.26	1.34
Return on Equity (ROE)	-2.58%	-4.00%	1.14%	0.24%	-2.77%	6.11%
Return on Assets (ROA)	1.14%	0.36%	2.55%	1.93%	-0.20%	2.96%
Return on Invested Capital (ROIC)	-22.17%	0.76%	1.13%	0.38%	-0.40%	4.62%
Return on Capital Employed (ROCE)	2.40%	0.70%	5.30%	4.20%	-0.40%	5.70%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 11, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	-0.64%	-1.80%	0.31%	0.10%	-2.28%	-
FCF Yield	-0.50%	4.21%	0.77%	1.71%	-5.89%	-
Dividend Yield	-	-	0.06%	0.08%	-	-
Payout Ratio	-	-	15.88%	-	-	13.30%
Buyback Yield / Dilution	-0.50%	0.40%	-3.67%	-7.85%	-0.95%	-87.83%
Total Shareholder Return	-0.50%	0.40%	-3.61%	-7.76%	-0.95%	-87.83%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error